Symptom management and successful outpatient transplantation for patients with multiple myeloma

Cancer Nursing

Volumn 25, Issue 6, 2002, Pages 452-460

  Coleman, Elizabeth Ann ^a   Coon, Sharon K ^a   Mattox, Sandra G ^a   O'Sullivan, Patricia ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Fatigue; Oral hydration; Outpatient; Patient education; Peripheral stem cell; Symptom management; Transplantation

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD CULTURE; CANCER PALLIATIVE THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; ENERGY; FEMALE; GENDER; HOSPITAL ADMISSION; HUMAN; HYDRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE MYELOMA; OUTPATIENT; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RELIGION; RETROSPECTIVE STUDY; SELF CARE; STEM CELL TRANSPLANTATION; TIME;

EID: 0036895731     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002820-200212000-00009     Document Type: Article

References (45)

1. Jagannath S, Vesole DH, Tricot G, Crowley J, Salmon SE, Barlogie B, et al. Hemopoietic stem cell transplants for multiple myeloma. Oncology. 1994;8(11):89-103.
2. Topolsky D, Biggs D. Transplantation in multiple myeloma. Semin Oncol 1995;22(3):230-237.
3. Appelbaum FR. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin. 1996;46(3): 142-164.
4. Crouch MA, Ross JA. Current concepts in autologous bone marrow transplantation. Semin Oncol Nurs. 1994;10(1):12-19.
5. Vesole DH, Tricot G, Jagannath S, et al. Autotransplants in multiple myeloma: What have we learned? Blood. 1996;88(3):838-847.
6. Hooper PJ, Santas EJ. Peripheral blood stem cell transplantation. Oncol Nurs Forum. 1993;20(8):1215-1221.
7. Henon PR. Peripheral blood stem cell transplantations: Past, present and future. Stem Cells. 1993;11(3):154-172.
8. Faucher C, le Corroller AG, Blaise D, et al. Comparison of G-CSFprimed peripheral blood progenitor cells and bone marrow auto transplantation: Clinical assessment and cost-effectiveness. Bone Marrow Transplant. 1994;14(6):895-901.
9. Williams HM. Cancer therapy: Reimbursement of new therapeutic technologies. Yale J Biol Med. 1992;65(2):83-97.
10. Hurd DD, Peters WP. Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage II or III breast cancer involving 10 or more axiilary lymph nodes (CALGB Protocol 9082). Cancer and Leukemia Group B. J Natl Cancer Inst Monogr. 1995;19:41-44.
11. Isaacs RE. Advances in the treatment of breast cancer: Balancing technology and economics. J Women's Health. 1995;4:15-26.
12. Houston DA, Houston GR. Administrative issues and concepts in ambulatory care. In: Buchsel PC, Yarbro CH, eds. Oncology Nursing in the Ambulatory Setting - Issues and Models of Care. London: Jones and Bartlett Publishers, International; 1996:3-19.
13. Nevidjon BM. The changing roles of oncology nurses in ambulatory care settings. In: Buchsel PC, Yarbro CH, eds. Oncology Nursing in the Ambulatory Setting - Issues and Models of Care. London: Jones and Bartlett Publishers, International; 1996:21-34.
14. Seeber S, Baird SB. The impact of health care changes on home health. Semin Oncol Nurs. 1996;12(3):179-187.
15. Cabello CC. Integration of inpatient and outpatient services in an acute care transplant unit. Prog Transplant. 2001;121(1):23-28.
16. Peters WP, Ross M, Vredenburgh JJ, et al. Role of cytokines in autologous bone marrow transplantation. Hematol Oncol Clin North Am. 1993;7(3):737-747.
17. Gahrton G, Svensson H, Cavo M, et al. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: A comparison between transplants performed 1983 - 93 and 1994 - 8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol. 2001;113(1):209-216.
18. Shea TC. Introduction: Current issues in high-dose chemotherapy and stem cell support. Bone Marrow Transplant. 1999;23(suppl 2):S1-S5.
19. Crilley P, Goldstein LJ. Peripheral blood stem cell transplant in breast cancer. Semin Oncol. 1995;22(3):238-249.
20. Bennett CL, et al. Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: Results from the University of Nebraska 1987 through 1991. J Clin Oncol. 1995;13(4): 969-973.
21. Tricot G, Jagannath S, Vesole DH, et al. Hematopoietic stem cell transplants for multiple myeloma. Leuk Lymphoma. 1996;22(1-2):25-36.
22. Rapsilber LM, Camp-Sorrell D. Ambulatory infusion pumps: Application to oncology. Semin Oncol Nurs. 1995;11(3):213-220.
23. Peters WP, Ross M, Vredenburgh JJ, et al. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer. Semin Oncol. 1994;21(4 Suppl 7):25-31.
24. Mangan KF. Peripheral blood stem cell transplantation: From laboratory to clinical practice. Semin Oncol. 1995;22(3):202-209.
25. Jassak PF, Riley MB. Autologous stem cell transplant: An overview. Cancer Pract. 1994;2(2):141-145.
26. Bredeson C, Malcolm J, Davis M, Bence-Bruckler I, Kearns B, Huelosch L. Cost analysis of the introduction of PBPC for autologous transplantation: Effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC). Bone Marrow Transplant. 1997;20(10):889-896.
27. Larson PJ. Perceptions of the needs of hospitalized patients undergoing bone marrow transplant. Cancer Pract. 1995;3(3):173-179.
28. Passik SD, Kirsh KL, Rosenfeld B, McDonald MV, Theobald DE. The changeable nature of patients' fears regarding chemotherapy: Implications for palliative care. J Pain Symptom Manage. 2001;21(2):113-120.
29. Curt GA. Fatigue in cancer. BMJ. 2001;322(7302):1560.
30. Thain CW, Gibbon B. An exploratory study of recipients' perceptions of bone marrow transplantation. J adv Nurs. 1996;23(3):528-535.
31. Given BA, Given CW. Family home care for individuals with cancer. Oncology. 1994;8(5):77-83, discussion 86-8, 93.
32. Larson PJ, Viele CS, Coleman S, Dibble SL, Cebulski O. Comparison of perceived symptoms of patients undergoing bone marrow transplant and the nurses caring for them. Oncol Nurs Forum. 1993;20(1):81-87, 87-88.
33. Buchsel PC. Ambulatory care: Before and after BMT. In: Whedon MB, ed. Bone Marrow Transplantation: Principles, Practice, and Nursing Insights. Boston: Jones and Bartlett; 1991:295-311.
34. Burns JM, Tierney DK, Long GD, Lambert SC, Carr BE. Critical pathway for administering high-dose chemotherapy followed by peripheral blood stem cell rescue in the outpatient setting. Oncol Nurs Forum. 1995;22(8):1219-1224.
35. Kurtz ME, Kurtz JC, Given CC, Given B. Concordance of cancer patient and caregiver symptom reports. Cancer Pract. 1996;4(4):185-190.
36. Moinpour CM. Measuring quality of life: An emerging science. Semin Oncol. 1994;21(5 suppl 10):48-60, 60-63.
37. American Cancer Society, Inc. Cancer Facts & Figures, 2000. Atlanta: American Cancer Society, Inc.; 2000.
38. Barlogie B, Jagannath S, Vesole DH, et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood. 1997;89(3):789-793.
39. Barlogie B. High-dose therapy and innovative approaches to treatment of multiple myeloma. Semin Hematol. 2001;38(2 suppl 3):21-27.
40. Barlogie B, Jagannath S, Desikan KR, et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood 1999;93(1):55-65.
41. Coon S. 17th International Cancer Congress Proceedings. in 17th International Cancer Congress. Bologna, Italy: Monduzzi Editore; 1998.
42. Summers N, Dawe U, Stewart DA. A comparison of inpatient and outpatient ASCT. Bone Marrow Transplant. 2000;26(4):389-395.
43. Jagannath S, Vesole DH, Zhang M, et al. Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma. Bone Marrow Transplant. 1997;20(6):445-450.
44. Siegel DS, Desikan KR, Mehta J, et al. Age is not a prognostic variable with autotransplants for multiple myeloma. Blood. 1999;93(1):51-54.
45. Atkinson A, Barsevick A, Cella D, et al. NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology. 2000;14(11A):151-161.